We recently posted about communicating with NIH Program Officers during your National Institutes of Health grant application journey. One of the milestones we highlighted was also the topic of an All About Grants podcast from early 2023, receiving and responding to reviewer critique.

We’re starting this series with a focus on Significance. This important section of an SBIR/STTR grant application is a pitfall that we have previously written about, but this time we’ll be going into more detail on how to convey this section to a reviewer.

Communication with your NIH program officer will provide you with valuable guidance and insight throughout your SBIR/STTR grant application and review experience. As an applicant, you’ll be navigating various NIH institutes and feedback processes that may be unfamiliar to you. Establishing clear lines of communication with a program officer will help steer you in the right direction.

Time for another AAG Unplugged! In this entry we’ll be summarizing an All About Grants episode that covers material that overlaps with one of our prior posts about managing your SBIR/STTR grant.

It is likely that your expertise is in the science of your innovation, not necessarily in the commercialization of that innovation. When you work with Blue Haven Grant Consultants, we’ll work with you refine those plans as part of our individualized BHGC Advantage.

National Institute of Health (NIH) reviewers have the difficult task of identifying promising innovations and identifying the teams that can turn that innovation into a workable project that will lead to commercialization and improvements in public health.

If you’re here it’s because you are an innovator. You’re exploring how to solve meaningful medical problems with your ideas and projects. That means you are producing Intellectual Property (IP).

As part of our service to the industry, we’re happy to provide brief summaries and take aways about podcasts and where we see BHGC being able to help you take that information and make it actionable. This episode discussed the general application process and the importance of the funding cycle.

At Blue Haven Grant Consultants we take pride in staying informed about NIH grant news. You can do the same by checking out their All About Grants Podcast. You might not have the time to listen to each episode, however. As part of our service to the industry, we’re happy to provide brief summaries and take aways about podcasts and where we see BHGC being able to help you take that information and make it actionable.

Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are two of the most popular sources for funding medical device innovation. Understanding the differences between these two grants is essential to making an informed decision about which grant is best suited for your project.

When it comes to securing funding from the National Institute of Health’s (NIH) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, it's not just about having a great idea – it's about how well you can communicate that idea.

If you were exploring investment in a medical device project, you would likely seek third party perspectives about whether that project had the resources, ideas, and team to make your investment worthwhile.

They say that seeing is believing. When it comes to applying for grant funding, your data is the “seeing” that the reviewers need in order to “believe.” Unfortunately, many applicants overlook data presentation, missing an opportunity to make a positive impact on reviewers.

We want you to obtain funding from the SBIR/STTR program. That’s our mission. Through our series of posts, we have discussed various aspects of the grant writing process, including why you should even hire a specialized grant writer.

Welcome to your new role as Project Manager!  If terms like agile, waterfall, scrum, lean, PMBOK, or Kanban are unfamiliar to you, worry not.

Typically, both SBIR Phase I and Phase II applications present preliminary data. However, the purpose of this preliminary data is different for Phase I and Phase II applications.

An experienced SBIR grant writer knows NIH SBIR proposal reviewers do the same thing when they scrutinize an application. When an application can demonstrate that the team has the tools and capability to get the project completed, it increases the likelihood that the application will be approved.

It's 3 am and your mind is racing about your SBIR/STTR application. You know you have a good project, but how will you ensure your research and develop tasks are accounted for and conveyed to a federal granting agency?

At Blue Haven Grant Consultants (BHGC), we have thought a lot about the process of securing funding for early-stage medical technology companies. Companies like yours are not only exciting economic opportunities but are also advancing the field of human health!

Many people have innovative brainstorms that end as ideas on a napkin. That’s not you. You’ve refined your idea and have started working through theoretical and practical challenges of your project. You feel like your idea is on the cusp of going from concept to commercialization.